Featured Research

from universities, journals, and other organizations

Blood Pressure Heads Down In The Absence Of Protein Involved In Metabolic Syndrome

Date:
February 17, 2007
Source:
Journal of Clinical Investigation
Summary:
One of the most serious health conditions in the developed world is the metabolic syndrome (MetS), a collection of disorders (such as obesity and insulin resistance) that lead to increased risk of developing type 2 diabetes and heart disease. A protein known as PPAR-gamma has been shown to affect most aspects of MetS.

One of the most serious health conditions in the developed world is the metabolic syndrome (MetS), a collection of disorders (such as obesity and insulin resistance) that lead to increased risk of developing type 2 diabetes and heart disease.

Related Articles


A protein known as PPAR-gamma has been shown to affect most aspects of MetS. However, these studies have had to focus on the affects of PPAR-gamma on one aspect of MetS at a time because mice lacking PPAR-gamma in all cells die before birth.

But now, Richard Morentsen, David Milstone, and colleagues have generated viable mice with a global PPAR-gamma defect and determined how the individual affects of PPAR-gamma manifest in the whole mouse.

In the study, which appears online on February 15 in advance of publication in the March print issue of the Journal of Clinical Investigation, the authors show that mice with a global PPAR-gamma defect are severely insulin resistant and have less fat than normal mice, although the latter is offset by an increase in the size of all the internal organs.

These changes were associated with a decrease in blood pressure (hypotension), which is surprising given that PPAR-gamma–stimulating drugs (known as thiazolidinediones) used to treat type 2 diabetes also decrease blood pressure. These mice will therefore be useful for further investigating whether PPAR-gamma mediates the effects of thiazolidinediones in individuals with type 2 diabetes and/or MetS.


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "Blood Pressure Heads Down In The Absence Of Protein Involved In Metabolic Syndrome." ScienceDaily. ScienceDaily, 17 February 2007. <www.sciencedaily.com/releases/2007/02/070215182608.htm>.
Journal of Clinical Investigation. (2007, February 17). Blood Pressure Heads Down In The Absence Of Protein Involved In Metabolic Syndrome. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2007/02/070215182608.htm
Journal of Clinical Investigation. "Blood Pressure Heads Down In The Absence Of Protein Involved In Metabolic Syndrome." ScienceDaily. www.sciencedaily.com/releases/2007/02/070215182608.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins